SCHEMBL30344700

SCHEMBL30344700

Cc1cc([N+](=O)[O-])c(OCC2CCN2C(=O)OC(C)(C)C)cc1C(=O)NC1(c2cccc3ccccc23)CC1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR1D1 P20393 4/20 0.34
▸ KDM1A O60341 1/20 0.33
▸ IL1B P01584 1/20 0.33
▸ P2RX7 Q99572 1/20 0.33
▸ HDAC8 Q9BY41 1/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ BCL2 P10415 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ BACE1 P56817 1/20 0.32
▸ CHEK1 O14757 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ CNR2 P34972 1/20 0.31
▸ F2RL3 Q96RI0 2/20 0.31
▸ SIRT6 Q8N6T7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30344494 0.88 SIRT6 (0.37) MEN1KMT2AALDH1A1GAAMAPT
SCHEMBL31360021 0.85 HDAC8 (0.40) NR1D1KDM1AIL1BP2RX7HDAC8
SCHEMBL31360320 0.85 HDAC8 (0.40) NR1D1KDM1AIL1BP2RX7HDAC8
SCHEMBL25155126 0.85 HDAC8 (0.40) NR1D1KDM1AIL1BP2RX7HDAC8
SCHEMBL25156047 0.85 HDAC8 (0.40) NR1D1KDM1AIL1BP2RX7HDAC8
SCHEMBL25156101 0.85 HDAC8 (0.40) NR1D1KDM1AIL1BP2RX7HDAC8
SCHEMBL30344427 0.85 HDAC8 (0.40) NR1D1KDM1AIL1BP2RX7HDAC8
SCHEMBL31360083 0.84 F2RL3 (0.35) MEN1KMT2ABCL2L3MBTL1ALDH1A1
SCHEMBL31360282 0.84 F2RL3 (0.35) MEN1KMT2ABCL2L3MBTL1ALDH1A1
SCHEMBL30344978 0.84 POLB (0.36) MEN1KMT2ABCL2L3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250025443-A1 COMPOUNDS AND METHODS FOR TREATING CORONA VIRUSES Clear Creek Bio, Inc. (US) 2025-01-23 — — US disclosed
WO-2023064493-A1 COMPOUNDS AND METHODS FOR TREATING CORONAVIRUSES Clear Creek Bio, Inc. (US) 2023-04-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250025443-A1 COMPOUNDS AND METHODS FOR TREATING CORONA VIRUSES ACE, PREP, PEPD NR1D1 3531/4885KDM1A 702/4885IL1B 1264/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback